logo

For the Inventor, By the Inventor

Brentwood, TN, United States of America

Eric P Skaar

USPTO Granted Patents = 10 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Brentwood, TN (US) (2014 - 2021)
  • Nashville, TN (US) (2012 - 2024)

Company Filing History:

goldMedal10 out of 1,163 
 
Vanderbilt University
 patents

Years Active: 2012-2024

Loading Chart...
10 patents (USPTO):Explore Patents
1. 11992520 - Human monoclonal antibodies toIsd proteins and uses thereof (2024-05-28),
2. 10914683 - Methods and systems for identification of bacteria in biological fluid using raman spectroscopy and applications of same (2021-02-09),
3. 10607721 - High-throughput, multi-omics approach to determine and validate de novo global mechanisms of action for drugs and toxins (2020-03-31),
4. 10538733 - Compositions and methods for treatment of bacterial infections (2020-01-21),
5. 10045966 - Compositions and methods for treating microbial infections (2018-08-14),
6. 9867879 - Methods for use of small molecule activators of hem-Y / protoporphyrinogen oxidase (PPO) (2018-01-16),
7. 9226947 - Methods for treating microbial infection (2016-01-05),
8. 8916163 - Method for treating microbial infections (2014-12-23),
9. 8632988 - Pathogen hemoglobin receptor specificity for human hemoglobin (2014-01-21),
10. 8263642 - Antimicrobial compounds and methods of use thereof (2012-09-11),

Title: The Innovations of Eric P Skaar: Pioneering Advances in Biotechnology

Introduction:

Eric P Skaar, a renowned inventor hailing from Brentwood, TN (US), is a trailblazer in the field of biotechnology. With a remarkable portfolio of 9 patents to his name, Skaar's work has significantly impacted the landscape of bacterial identification and drug mechanism research.

Latest Patents:

Among his latest patents is the groundbreaking invention titled "Methods and Systems for Identification of Bacteria in Biological Fluid Using Raman Spectroscopy and Applications of Same." This method revolutionizes bacterial identification by utilizing Raman spectroscopy to discern between different bacterial strains present in biological fluids with unparalleled accuracy.

Another noteworthy patent is the "High-throughput, Multi-omics Approach to Determine and Validate De Novo Global Mechanisms of Action for Drugs and Toxins." This invention streamlines the identification of drug and toxin mechanisms of action within a rapid timeframe of 30 days or less, employing high-throughput bioinformatics and pathway analysis techniques.

Career Highlights:

Eric P Skaar is a key figure at Vanderbilt University, where his innovative research and inventive spirit drive advancements in biotechnology. His expertise and dedication have propelled him to the forefront of the field, earning him recognition for his groundbreaking contributions.

Collaborations:

Skaar collaborates closely with esteemed colleagues such as Gary Allen Sulikowski and Paul R Reid, forging partnerships that further amplify the impact of his research. Together, they work towards pioneering new frontiers in biotechnology and drug discovery.

Conclusion:

In conclusion, Eric P Skaar's visionary work underscores his commitment to pushing the boundaries of innovation in biotechnology. His patents stand as a testament to his ingenuity and unwavering pursuit of scientific excellence, cementing his legacy as a leading figure in the field of bacterial identification and drug mechanism research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…